Marine Drugs (May 2014)

Echinochrome A Protects Mitochondrial Function in Cardiomyocytes against Cardiotoxic Drugs

  • Seung Hun Jeong,
  • Hyoung Kyu Kim,
  • In-Sung Song,
  • Seon Joong Lee,
  • Kyung Soo Ko,
  • Byoung Doo Rhee,
  • Nari Kim,
  • Natalia P. Mishchenko,
  • Sergey A. Fedoryev,
  • Valentin A. Stonik,
  • Jin Han

DOI
https://doi.org/10.3390/md12052922
Journal volume & issue
Vol. 12, no. 5
pp. 2922 – 2936

Abstract

Read online

Echinochrome A (Ech A) is a naphthoquinoid pigment from sea urchins that possesses antioxidant, antimicrobial, anti-inflammatory and chelating abilities. Although Ech A is the active substance in the ophthalmic and cardiac drug Histochrome®, its underlying cardioprotective mechanisms are not well understood. In this study, we investigated the protective role of Ech A against toxic agents that induce death of rat cardiac myoblast H9c2 cells and isolated rat cardiomyocytes. We found that the cardiotoxic agents tert-Butyl hydroperoxide (tBHP, organic reactive oxygen species (ROS) inducer), sodium nitroprusside (SNP; anti-hypertension drug), and doxorubicin (anti-cancer drug) caused mitochondrial dysfunction such as increased ROS level and decreased mitochondrial membrane potential. Co-treatment with Ech A, however, prevented this decrease in membrane potential and increase in ROS level. Co-treatment of Ech A also reduced the effects of these cardiotoxic agents on mitochondrial oxidative phosphorylation and adenosine triphosphate level. These findings indicate the therapeutic potential of Ech A for reducing cardiotoxic agent-induced damage.

Keywords